{"title":"Middle Aortic Syndrome Presented in Pregnancy-Treated with Percutaneous Intervention Followed by Successful Management of the Complications","authors":"Niari Jayakrishna, Gutte Avinash A, Waghmare Nagesh, Munde Kalyan S, Mutha Samkit, Kolapkar Hariom","doi":"10.23937/2378-2951/1410292","DOIUrl":"https://doi.org/10.23937/2378-2951/1410292","url":null,"abstract":"Introduction: Mid-aortic syndrome is a clinical condition characterized by segmental narrowing of the abdominal or descending thoracic aorta, often resulting in severe hypertension. It can manifest as either a congenital abnormality or as one of several acquired conditions. Given the limited evidence available on the treatment of this syndrome, various approaches have been reported, including surgical intervention and endovascular treatments such as stent placement and medical management alone. Objective: To determine the prevalence of ACS patients and the risk factors of in-hospital mortality of STEMI patients at Bekasi District General Hospital in 2021. Case presentation: We present the case of a 21-year-old female who developed life-threatening hypertension during the 21st week of pregnancy, a condition that went unrecognized before gestation due to the rarity of this syndrome. Unfortunately, in our patient, arterial hypertension proved resistant to a 4-drug antihypertensive regimen and there is evidence of end organ damage and fetal compromise. However following termination of pregnancy, a successful endovascular repair of mid-aortic syndrome was achieved using a self-expanding stent, along with bilateral renal artery stenting. Following the procedure, patient developed haemorrhagic stroke which was managed successfully and patient discharged in a stable condition. Conclusion: Patient is doing well for the last 11 months. Mid-aortic syndrome presented in pregnancy can be successfully managed with percutaneous intervention.","PeriodicalId":112011,"journal":{"name":"International Journal of Clinical Cardiology","volume":"21 12","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140359708","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Prevalence and Risk Factors of In-Hospital Mortality of ST Elevation Myocardial Infarction (STEMI) Patients during January-December 2021 at Bekasi District General Hospital","authors":"Syauqi Khanza Rizqullah, Akhmad Mailani Karina, Siregar Omar Mokhtar","doi":"10.23937/2378-2951/1410291","DOIUrl":"https://doi.org/10.23937/2378-2951/1410291","url":null,"abstract":"Background: Acute coronary syndrome (ACS) is a major cardiovascular problem. According to the World Health Organization (WHO) in 2015, cardiovascular disease caused 17.5 million deaths, while ACS caused 7.4 million deaths. ACS is a condition when the plaques are accumulated in coronary arteries that supply oxygen to the heart muscles. The ST-Elevation Myocardial Infarction (STEMI) is an indicator of total coronary artery occlusion. This condition requires revascularization to restore blood flow and myocardial reperfusion using fibrinolytic agents or primary Percutaneous Coronary Intervention (PCI). Early reperfusion therapy can reduce in-hospital mortality and show better outcomes in ACS patients. Objective: To determine the prevalence of ACS patients and the risk factors of in-hospital mortality of STEMI patients at Bekasi District General Hospital in 2021. Methods: This research was a descriptive cross-sectional study using secondary data from medical records. The data were presented in diagrams and tables. Results: There were 117 cases of ACS in 2021. They were 14% STEMI, 15% Non-ST Elevation Myocardial Infarction (NSTEMI), and 71% Unstable Angina Pectoris (UAP). Most patients were male (54%), and aged < 65-years-old (85%). The in-hospital mortality was 19% STEMI, 17% NSTEMI, and 12% UAP. Among 16 STEMI patients, 81% were male and 94% were aged < 65-years-old. There were 69% who came to the emergency room < 12 hours and only 50% underwent fibrinolytic. Conclusion: The risk factors of in-hospital mortality of STEMI patients were 40% late onset, 23% anterior STEMI, 20% hypertension, 60% diabetes mellitus, 50% chronic kidney disease, 33% tachycardia, and 100% Killip III.","PeriodicalId":112011,"journal":{"name":"International Journal of Clinical Cardiology","volume":"7 10","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140359327","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
David Billy Joseph, Maderazo Donna Aurea, Gaspar-Cabrera Dianne Camille, Castro Rod
{"title":"Dengue Myocarditis with Gitelman Syndrome Presenting as Arrhythmic Syncope: A Case Report of Acute Fulminant Dengue Myocarditis Resulting to Acquired Long QT Syndrome","authors":"David Billy Joseph, Maderazo Donna Aurea, Gaspar-Cabrera Dianne Camille, Castro Rod","doi":"10.23937/2378-2951/1410289","DOIUrl":"https://doi.org/10.23937/2378-2951/1410289","url":null,"abstract":"","PeriodicalId":112011,"journal":{"name":"International Journal of Clinical Cardiology","volume":"28 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140419865","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Bowden Rodney G, Richardson Kathleen A, Richardson Luke T
{"title":"Uric Acid as a Novel Component of Metabolic Syndrome","authors":"Bowden Rodney G, Richardson Kathleen A, Richardson Luke T","doi":"10.23937/2378-2951/1410278","DOIUrl":"https://doi.org/10.23937/2378-2951/1410278","url":null,"abstract":"Objective: Uric continues to be explored as a novel risk factor for Metabolic Syndrome. The purpose of our study was to identify risk factors that are associated with hyperuricemia and to better understand if uric acid might serve as a useful component of metabolic syndrome. Methods: A cross-sectional data analysis was conducted using the 2013-2018 NHANES datasets. Sample weights were assigned by NHANES researchers to each participant allowing researchers to generalize results to all non-institutionalized US civilians. The analysis included 6,432 individuals, which were representative of 94,729,059 US citizens. Results: We demonstrated that the risk factors that had a statistically significant relationship with UA value were fasting glucose, triglycerides, systolic BP, and waist circumference. Fasting blood glucose had an inverse relationship with UA level, indicating that for every 1-point increase in fasting blood glucose, uric acid level decreased slightly. The most adjusted model reports HDL also demonstrated an inverse relationship with UA but this relationship was attenuated after controlling for potential confounders. Triglyceride level, systolic BP, and WC had direct relationships with UA level, indicating that as each risk factor increased, UA level also increased. Waist circumference had the greatest clinical significance for UA level. Conclusions: The findings from our study suggest that metabolic syndrome risk factors do have a relationship with UA level, both in the total population and in those with metabolic syndrome. We found general trends that indicated that fasting blood glucose and HDL had negative relationships with UA level, whereas triglycerides, systolic BP, and waist circumference have positive relationships with UA. Diastolic BP did not demonstrate a relationship with UA level, and the relationship between HDL and UA was attenuated after adjustment for confounding variables. The findings suggest a need to further explore UA as a novel risk factor for metabolic syndrome.","PeriodicalId":112011,"journal":{"name":"International Journal of Clinical Cardiology","volume":"26 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"129757254","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Makhija Aman, Vanani Jignesh, Mohanty Arun, S. Manchanda, Dhawan Shashi, Garg Shilpa, Malik Manish, R. Mantri
{"title":"Non-Uremic Calciphylaxis in Patient of Non Recovered Postpartum Cardiomyopathy with Apla Syndrome","authors":"Makhija Aman, Vanani Jignesh, Mohanty Arun, S. Manchanda, Dhawan Shashi, Garg Shilpa, Malik Manish, R. Mantri","doi":"10.23937/2378-2951/1410275","DOIUrl":"https://doi.org/10.23937/2378-2951/1410275","url":null,"abstract":"","PeriodicalId":112011,"journal":{"name":"International Journal of Clinical Cardiology","volume":"164 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"127303271","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Villarino Resti Tito H, Villarino Maureen Lorence F
{"title":"Effects of Performance Enhancement Drugs on Body Mass Index, Blood Pressure, and Blood Sugar Levels on a Healthy Adult Male: A Case Study","authors":"Villarino Resti Tito H, Villarino Maureen Lorence F","doi":"10.23937/2378-2951/1410274","DOIUrl":"https://doi.org/10.23937/2378-2951/1410274","url":null,"abstract":"","PeriodicalId":112011,"journal":{"name":"International Journal of Clinical Cardiology","volume":"35 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"122825065","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"siRNA-Induced Silencing of LP(a) Gene: An Ideal Choice to Prevent Genetic Risk of Myocardial Infarction","authors":"Arslan Muhammad","doi":"10.23937/2378-2951/1410271","DOIUrl":"https://doi.org/10.23937/2378-2951/1410271","url":null,"abstract":"","PeriodicalId":112011,"journal":{"name":"International Journal of Clinical Cardiology","volume":"46 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"128042834","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}